Xtant Medical Holdings, Inc. (XTNT)
NYSEAMERICAN: XTNT · Real-Time Price · USD
0.6160
+0.0057 (0.93%)
Dec 5, 2025, 4:00 PM EST - Market closed

Xtant Medical Holdings Stock Forecast

Stock Price Forecast

The 1 analyst with a 12-month price forecast for Xtant Medical Holdings stock has a target of 1.50, which predicts a 143.51% increase from the current stock price of 0.62.

Price Target: $1.50 (+143.51%)
Analyst Consensus: Strong Buy
Target Low Average Median High
Price $1.50 $1.50 $1.50 $1.50
Change +143.51% +143.51% +143.51% +143.51%

Analyst Ratings

According to 1 stock analyst, the rating for Xtant Medical Holdings is "Strong Buy". This means that the analyst believes this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating Jul '25Aug '25Sep '25Oct '25Nov '25Dec '25
Strong Buy 222211
Buy 000000
Hold 000000
Sell 000000
Strong Sell 000000
Total 222211

Latest Forecasts

Analyst Firm Rating Rating Action Price Target Upside Date
BTIG
BTIG
Strong Buy
Maintains
$2$1.5
Strong Buy Maintains $2$1.5 +143.51% Nov 11, 2025
BTIG
BTIG
Strong Buy
Maintains
$2$3
Strong Buy Maintains $2$3 +387.01% May 16, 2024
BTIG
BTIG
Strong Buy
Initiates
$2
Strong Buy Initiates $2 +224.68% Dec 5, 2023
Craig-Hallum
Craig-Hallum
Strong Buy
Maintains
$1$1.2
Strong Buy Maintains $1$1.2 +94.81% Jul 11, 2023
Craig-Hallum
Craig-Hallum
Strong Buy
Initiates
$1
Strong Buy Initiates $1 +62.34% Apr 26, 2023
More Analyst Ratings

Financial Forecast

Revenue This Year
135.97M
from 117.27M
Increased by 15.95%
Revenue Next Year
115.67M
from 135.97M
Decreased by -14.93%
EPS This Year
0.03
from -0.12
EPS Next Year
0.01
from 0.03
Decreased by -80.00%
Fiscal Year FY 2020 FY 2021 FY 2022 FY 2023 FY 2024 FY 2025 FY 2026
Period Ending Dec 31, 2020 Dec 31, 2021 Dec 31, 2022 Dec 31, 2023 Dec 31, 2024 Dec 31, 2025 Dec 31, 2026
Revenue
53.34M55.26M57.97M91.30M117.27M135.97M115.67M
Revenue Growth
-17.54%3.61%4.90%57.50%28.44%15.95%-14.93%
EPS
-0.25-0.06-0.090.01-0.120.030.01
EPS Growth
-------80.00%
Forward PE
-----24.16120.78
No. Analysts
-----44
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue 202520262027
High 140.2M 131.4M
Avg 136.0M 115.7M
Low 130.4M 99.7M

Revenue Growth

Revenue Growth 202520262027
High
19.5%
-3.4%
Avg
15.9%
-14.9%
Low
11.2%
-26.7%

EPS Forecast

EPS 202520262027
High 0.03 0.01
Avg 0.03 0.01
Low 0.02 -

EPS Growth

EPS Growth 202520262027
High -
-58.8%
Avg -
-80.0%
Low - -
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.